⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LYEL News
Lyell Immunopharma, Inc. Common Stock
Lyell Immunopharma To Participate in the Baird 2026 Global Healthcare Conference
globenewswire.com
LYEL
Form 8-K
sec.gov
LYEL
Lyell Immunopharma Completes Manufacturing Transfer for LYL273 and Provides Updated Timeline on Phase 1/2 Trial in Metastatic Colorectal Cancer
globenewswire.com
LYEL
CAR T-cell Therapy for NHL Clinical Trial Landscape Expands: Over 70 Companies Advancing Next-Generation Therapies | DelveInsight
globenewswire.com
NVS
ALLO
LEGN
CBIO
MBIO
CRSP
INCY
IMPP
SANA
VOR
CARG
AUTL
ARCL
LYEL
PRE
BEAM
CART
TAK
AZN
MRK
BMY
GEN
DGX
GMAB
ABBV
RLGT
CRGO
JNJ
GILD
JAZZ
SYBX
CASI
ATRA
SHEN
BIIB
VREX
Form 8-K
sec.gov
LYEL
Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2026
globenewswire.com
LYEL
Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2026
globenewswire.com
LYEL
Lyell Immunopharma Announces Participation in H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
globenewswire.com
LYEL
Form 8-K
sec.gov
LYEL
Lyell Immunopharma Presents Updated Safety Data and Translational Insights for Rondecabtagene Autoleucel (Ronde-Cel) in Patients with Large B-Cell Lymphoma at European Hematology Association 2026 Congress
globenewswire.com
LYEL